In uninfected household contacts of patients with COVID-19, REGEN-COV reduced symptomatic COVID-19 at 28 d.
Where this comes from
- Record sourced from PubMed, PMID 34978854.
- Also identified by DOI 10.7326/J21-0008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
O'Brien MP, Forleo-Neto E, Musser BJ, et al. <b>Subcutaneous REGEN-COV antibody combination to prevent Covid-19.</b> N Engl J Med. 2021;385:1184-95. 34347950.
Medical subject headings
- COVID-19